Elevance Health Inc. Discloses Political Contributions to Leadership Committees
Elevance Health Inc. made political contributions to leadership committees for gubernatorial candidates in September 2026.
Stocks · News reference
TD Cowen Maintains Buy on Elevance Health, Raises Price Target to $495
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
THC Q3 Earnings Beat on Hospital Strength, 2026 EPS View Raised
Tenet Healthcare (THC) delivered robust third-quarter 2026 results with adjusted EPS of $6.64, up 79.5% year-over-year and beating estimates by 44.4%. Revenues grew 6.5% to $5.6 billion, driven by higher admissions, pricing strength, and disciplined cost management. The company raised its full-year 2026 adjusted EPS guidance to $22.05-$23.01 and EBITDA guidance to $5.05-$5.2 billion. Hospital EBITDA surged 34.8% to $818 million, while the company generated $1.1 billion in free cash flow and repurchased $255 million in shares.
Elevance Health Files for Mixed Shelf Offering
Elevance Health has filed for a mixed shelf offering, allowing the company to issue various types of securities in the future.
Evercore ISI Adjusts Price Target on Elevance Health to $440 From $460
Evercore ISI has revised its price target for Elevance Health, lowering it from $460 to $440.
Elevance Health Price Target Raised by US Capital Advisors
US Capital Advisors has increased its price target for Elevance Health to $492.00 per share from $473.00.
Senators Query Elevance Health Regarding CMS Data Requests and Coverage Terminations
Elevance Health is among several major health insurers receiving inquiries from U.S. senators regarding their compliance with CMS data requests that allegedly led to the termination of coverage for numerous enrollees.